Wellington Management Group’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-3,319,922
| Closed | -$145M | – | 1956 |
|
|
2023
Q3 | $145M | Sell |
3,319,922
-68,443
| -2% | -$2.98M | 0.03% | 444 |
|
|
2023
Q2 | $122M | Buy |
3,388,365
+692,273
| +26% | +$25M | 0.02% | 495 |
|
|
2023
Q1 | $100M | Sell |
2,696,092
-320,243
| -11% | -$11.9M | 0.02% | 536 |
|
|
2022
Q4 | $137M | Sell |
3,016,335
-452,976
| -13% | -$20.5M | 0.03% | 462 |
|
|
2022
Q3 | $242M | Buy |
3,469,311
+563,281
| +19% | +$39.3M | 0.05% | 323 |
|
|
2022
Q2 | $195M | Buy |
2,906,030
+423,509
| +17% | +$28.4M | 0.04% | 380 |
|
|
2022
Q1 | $204M | Sell |
2,482,521
-664,294
| -21% | -$54.6M | 0.04% | 412 |
|
|
2021
Q4 | $462M | Sell |
3,146,815
-293,407
| -9% | -$43M | 0.07% | 247 |
|
|
2021
Q3 | $609M | Buy |
3,440,222
+336,737
| +11% | +$59.6M | 0.1% | 199 |
|
|
2021
Q2 | $501M | Buy |
3,103,485
+917,067
| +42% | +$148M | 0.08% | 234 |
|
|
2021
Q1 | $375M | Sell |
2,186,418
-68,464
| -3% | -$11.7M | 0.07% | 288 |
|
|
2020
Q4 | $495M | Buy |
2,254,882
+617,462
| +38% | +$136M | 0.09% | 217 |
|
|
2020
Q3 | $272M | Sell |
1,637,420
-167,281
| -9% | -$27.8M | 0.06% | 293 |
|
|
2020
Q2 | $206M | Buy |
1,804,701
+68,744
| +4% | +$7.85M | 0.05% | 343 |
|
|
2020
Q1 | $133M | Buy |
1,735,957
+1,140,777
| +192% | +$87.7M | 0.04% | 400 |
|
|
2019
Q4 | $76.7M | Buy |
595,180
+444,295
| +294% | +$57.3M | 0.02% | 642 |
|
|
2019
Q3 | $11.8M | Buy |
150,885
+106,538
| +240% | +$8.3M | ﹤0.01% | 1108 |
|
|
2019
Q2 | $4.57M | Buy |
44,347
+34,658
| +358% | +$3.57M | ﹤0.01% | 1396 |
|
|
2019
Q1 | $710K | Buy |
+9,689
| New | +$710K | ﹤0.01% | 1834 |
|
|
2018
Q3 | – | Sell |
-9,522
| Closed | -$469K | – | 2337 |
|
|
2018
Q2 | $469K | Buy |
+9,522
| New | +$469K | ﹤0.01% | 2056 |
|